Follow The Filings

LH Labcorp

Labcorp earnings company data as of 1:58 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 4.65 — —
Rev — — —

Insider trades

Open-market buys and sales by LH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LH insider trades
  • None no insider bought on the open market
  • $5.5M sold by 6 insiders outside a trading plan
  • $8.2M sold by 6 insiders under 10b5-1 plans
  1. Kerrii B Anderson Director
    Planned sale
    $954K 3,000 shares at $318.02 31% of stake
    Traded Aug 17 Filed Aug 18
  2. Adam H Schechter CEO
    Planned sale
    $1.5M 4,669 shares at $320.37 4.4% of stake
    Traded Aug 11 Filed Aug 12
  3. Amy B. Summy EVP, Chief Marketing Officer
    Sale
    $283K 924 shares at $306.74 12% of stake
    Traded Aug 4 Filed Aug 6
  4. Peter J Wilkinson SVP, Chief Accounting Officer
    Sale
    $439K 1,420 shares at $309.23 45% of stake
    Traded Aug 3 Filed Aug 5
  5. Kathryn W Kyle EVP, Chief Legal Officer
    Planned sale
    $26K 92 shares at $286.19 2.3% of stake
    Traded Jul 2 Filed Jul 6
  6. Bryan T Vaughn EVP and President, Diagnostics
    Planned sale
    $67K 234 shares at $286.19 3.4% of stake
    Traded Jul 2 Filed Jul 6
  7. Kathryn W Kyle EVP, Chief Legal Officer
    Planned sale
    $201K 762 shares at $263.89 17% of stake
    Traded Jun 8 Filed Jun 10
  8. Adam H Schechter CEO
    Planned sale
    $1.5M 5,903 shares at $254.50 5.2% of stake
    Traded May 11 Filed May 13
  9. Peter J Wilkinson SVP, Chief Accounting Officer
    Planned sale
    $436K 1,633 shares at $267.05 47% of stake
    Traded Mar 27 Filed Mar 30
  10. Jonathan C Meltzer EVP, Operations
    Planned sale
    $224K 839 shares at $267.05 19% of stake
    Traded Mar 27 Filed Mar 30
  11. Adam H Schechter CEO
    Sale
    $2.4M 8,705 shares at $279.96 9.7% of stake
    Traded Mar 3 Filed Mar 5
  12. Sandra D Van Der Vaart EVP, Corporate Affairs
    Sale
    $156K 548 shares at $284.91 18% of stake
    Traded Feb 27 Filed Mar 3
  13. Brian J Caveney EVP, Pres of ED, CMO & CSO
    Sale
    $429K 1,500 shares at $286.31 4.7% of stake
    Traded Feb 24 Filed Feb 26
  14. Peter J Wilkinson SVP, Chief Accounting Officer
    Planned sale
    $185K 666 shares at $277.94 26% of stake
    Traded Feb 19 Filed Feb 23
  15. Adam H Schechter CEO
    Planned sale
    $1.5M 5,273 shares at $284.38 5.7% of stake
    Traded Feb 11 Filed Feb 13

Also filed in the last 12 months, not counted as buying or selling: 60 share withholdings for taxes, 55 option exercises, and 14 stock grants.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.02
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.07
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
DEF 14A
DEFA14A
8-K 7.01,9.01
8-K 7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.